HS Fund
www.hsfund.com
9
Leaving SiteNav
External Link Disclaimer
You are about to visit www.hsfund.com. This website is not operated by us. We are not responsible for its content or privacy practices.
About this website
HS Fund is a prominent Chinese financial services company specializing in private equity and venture capital investments. Founded in 2006, the company is headquartered in Shanghai, China. HS Fund operates under the legal name Shanghai Hongsheng Investment Management Co., Ltd. and has grown to become one of the most active private equity firms in China, managing assets under management exceeding 100 billion RMB. The company serves a diverse portfolio of high-net-worth individuals and institutional investors, with an estimated user base of over 10,000 clients across its various funds and investment products. HS Fund reported annual revenue of approximately 2.5 billion RNY in 2022, primarily derived from management fees and performance-based incentives. The firm offers a comprehensive range of services including private equity investments, venture capital financing, and real estate investment trusts, with a particular focus on technology, healthcare, and consumer sectors. HS Fund has established strategic partnerships with leading international financial institutions such as BlackRock and Morgan Stanley, enabling cross-border investment opportunities. The company has received numerous accolades, including being named Best Private Equity Firm in China by FinanceAsia for three consecutive years from 2020 to 2022. HS Fund operates with licenses from the China Securities Regulatory Commission and is a member of the Global Private Equity Association. Its key features include AI-driven investment analytics, a proprietary due diligence platform, and a dedicated team of over 200 investment professionals with extensive industry expertise. The firm is known for its rigorous investment thesis, focusing on companies with strong market positions and scalable business models.
Tags & Categories
Categories
Tags
Statistics
9
Views
0
Clicks
0
Like
0
Dislike